These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 6375400)

  • 1. Desipramine in the treatment of adolescents with attention deficit disorder.
    Gastfriend DR; Biederman J; Jellinek MS
    Am J Psychiatry; 1984 Jul; 141(7):906-8. PubMed ID: 6375400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Desipramine in the treatment of children with attention deficit disorder.
    Biederman J; Gastfriend DR; Jellinek MS
    J Clin Psychopharmacol; 1986 Dec; 6(6):359-63. PubMed ID: 3805329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Desipramine treatment of children with attention-deficit hyperactivity disorder and tic disorder or Tourette's syndrome.
    Spencer T; Biederman J; Kerman K; Steingard R; Wilens T
    J Am Acad Child Adolesc Psychiatry; 1993 Mar; 32(2):354-60. PubMed ID: 8444765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Desipramine in the treatment of attention deficit disorder in adolescents.
    Gastfriend DR; Biederman J; Jellinek MS
    Psychopharmacol Bull; 1985; 21(1):144-5. PubMed ID: 3983334
    [No Abstract]   [Full Text] [Related]  

  • 5. Cardiovascular effects of desipramine in children.
    Schroeder JS; Mullin AV; Elliott GR; Steiner H; Nichols M; Gordon A; Paulos M
    J Am Acad Child Adolesc Psychiatry; 1989 May; 28(3):376-9. PubMed ID: 2661525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and neuropsychological effects of desipramine in children with attention deficit hyperactivity disorder.
    Gualtieri CT; Keenan PA; Chandler M
    J Clin Psychopharmacol; 1991 Jun; 11(3):155-9. PubMed ID: 2066453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A systematic review of the efficacy and safety of desipramine for treating ADHD.
    Ghanizadeh A
    Curr Drug Saf; 2013 Jul; 8(3):169-74. PubMed ID: 23914752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Desipramine treatment of boys with attention-deficit hyperactivity disorder and tics: preliminary clinical experience.
    Riddle MA; Hardin MT; Cho SC; Woolston JL; Leckman JF
    J Am Acad Child Adolesc Psychiatry; 1988 Nov; 27(6):811-4. PubMed ID: 3198572
    [No Abstract]   [Full Text] [Related]  

  • 9. Cardiovascular effects of desipramine in children and adolescents with attention deficit disorder.
    Biederman J; Gastfriend D; Jellinek MS; Goldblatt A
    J Pediatr; 1985 Jun; 106(6):1017-20. PubMed ID: 3998940
    [No Abstract]   [Full Text] [Related]  

  • 10. Desipramine and cutaneous reactions in pediatric outpatients.
    Biederman J; Gonzalez E; Bronstein B; De Monaco H; Wright V
    J Clin Psychiatry; 1988 May; 49(5):178-83. PubMed ID: 2966797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacologic treatment of attention deficit hyperactivity disorder.
    Greenhill LL
    Psychiatr Clin North Am; 1992 Mar; 15(1):1-27. PubMed ID: 1347936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth deficits in children treated with desipramine: a controlled study.
    Spencer T; Biederman J; Wright V; Danon M
    J Am Acad Child Adolesc Psychiatry; 1992 Mar; 31(2):235-43. PubMed ID: 1564024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A double-blind placebo controlled study of desipramine in the treatment of ADD: I. Efficacy.
    Biederman J; Baldessarini RJ; Wright V; Knee D; Harmatz JS
    J Am Acad Child Adolesc Psychiatry; 1989 Sep; 28(5):777-84. PubMed ID: 2676967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tourette's syndrome with symptoms of attention deficit disorder treated with desipramine.
    Linet LS
    J Clin Psychiatry; 1987 Nov; 48(11):456. PubMed ID: 3479424
    [No Abstract]   [Full Text] [Related]  

  • 15. Resolved: cardiac arrhythmias make desipramine an unacceptable choice in children.
    Werry JS; Biederman J; Thisted R; Greenhill L; Ryan N
    J Am Acad Child Adolesc Psychiatry; 1995 Sep; 34(9):1239-45; discussion 1245-8. PubMed ID: 7559320
    [No Abstract]   [Full Text] [Related]  

  • 16. A naturalistic study of 24-hour electrocardiographic recordings and echocardiographic findings in children and adolescents treated with desipramine.
    Biederman J; Baldessarini RJ; Goldblatt A; Lapey KA; Doyle A; Hesslein PS
    J Am Acad Child Adolesc Psychiatry; 1993 Jul; 32(4):805-13. PubMed ID: 8340302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A review of studies of drug treatment efficacy for attention deficit disorder with hyperactivity in adolescents.
    Varley CK
    Psychopharmacol Bull; 1985; 21(2):216-21. PubMed ID: 2860692
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of attention-deficit/hyperactivity disorder.
    Jadad AR; Boyle M; Cunningham C; Kim M; Schachar R
    Evid Rep Technol Assess (Summ); 1999 Nov; (11):i-viii, 1-341. PubMed ID: 10790990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The treatment of attention-deficit hyperactivity disorder in Tourette's syndrome: a double-blind placebo-controlled study with clonidine and desipramine.
    Singer HS; Brown J; Quaskey S; Rosenberg LA; Mellits ED; Denckla MB
    Pediatrics; 1995 Jan; 95(1):74-81. PubMed ID: 7770313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case of Tourette's syndrome with symptoms of attention deficit disorder treated with desipramine.
    Hoge SK; Biederman J
    J Clin Psychiatry; 1986 Sep; 47(9):478-9. PubMed ID: 3462186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.